The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis

Archives of Dermatology
G G KruegerR A Chandraratna

Abstract

To determine the safety and efficacy of topically applied tazarotene gel in the treatment of mild to moderate psoriatic plaques. Two multicenter, double-blind, randomized studies of 6- and 8-week duration, with an 8-week follow-up in the second study. Medical center outpatient dermatology services. One hundred fifty-three adults with 2 bilateral target plaques on the trunk, legs, or arms. Vehicle gel or 0.01% and 0.05% tazarotene gel administered twice daily to 45 patients (study A), or 0.05% and 0.1% tazarotene gel administered either once or twice daily to 108 patients (study B). Treatment success and plaque elevation, scaling, and erythema vs time. The 0.01% tazarotene gel showed minimal efficacy. Applications of 0.05% and 0.1% tazarotene gels administered once or twice daily, resulted in significant improvements in plaque elevation, scaling, erythema, and overall clinical severity as early as 1 week. Treatment success rates (defined as > 75% improvement from baseline) were 45% with 0.05% tazarotene gel vs 13% with vehicle gel after 6 weeks of treatment (P < .05; study A) and ranged from 48% to 63% with the various tazarotene treatment regimens after 8 weeks of treatment (study B). These improvements were evident at the 8-we...Continue Reading

Citations

Apr 16, 2002·The British Journal of Dermatology·J MasonM J Cork
Jan 15, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·V SchleyerR-M Szeimies
Apr 17, 2004·Skin Pharmacology and Physiology·A RoederH C Korting
Apr 1, 2004·Expert Opinion on Therapeutic Patents·Nicolò Pipitone, Costantino Pitzalis
Mar 10, 2010·Expert Opinion on Drug Metabolism & Toxicology·Rakhashandra TalpurMadeleine Duvic
Nov 4, 2000·Expert Opinion on Investigational Drugs·D DiSepio, R A Chandraratna
Oct 31, 2009·Clinical and Experimental Dermatology·U KumarB Kumar
Jan 8, 2000·Dermatologic Clinics·M Lebwohl
Jun 22, 2005·Journal of the American Academy of Dermatology·Mark Lebwohl
Feb 19, 2015·Therapeutic Delivery·Anthony P RaphaelTarl W Prow
Nov 22, 2014·Dermatologic Clinics·Peter C M van de Kerkhof
Sep 24, 2005·Journal of Mass Spectrometry : JMS·Petr FrycákKarel Lemr
Jun 6, 2019·Brazilian Dental Journal·Eveline Claudia MartiniAlessandra Reis
Dec 19, 2018·The Cochrane Database of Systematic Reviews·Prashanti EachempatiIbrahim Ethem Yaylali
Oct 21, 2006·The Cochrane Database of Systematic Reviews·H HassonG Neiva
Aug 22, 2008·Periodontology 2000·Munther A M Sulieman
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Anne R MasonHelen Hancock
May 4, 2010·Journal of Esthetic and Restorative Dentistry : Official Publication of the American Academy of Esthetic Dentistry ... [et Al.]·Murat TürkünNecmi Gökay
Aug 24, 2011·Operative Dentistry·P F L DawsonP A Brunton
Dec 7, 2007·Operative Dentistry·Bruce A MatisJeremy I Matis
Apr 15, 2009·Operative Dentistry·Bruce A MatisGeorge Eckert
Aug 3, 2010·Operative Dentistry·Juliana B da CostaJack L Ferracane
Nov 2, 2001·Paediatric Drugs·J Leman, D Burden
Apr 27, 2002·Journal of Cutaneous Medicine and Surgery·Jean-François Tremblay, Robert Bissonnette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.